Addario Lung Cancer Medical Institute
Data sourced from IRS 990 public filings
Addario Lung Cancer Medical Institute The Addario Lung Cancer Medical Institute ALCMI is dedicated to catalyzing and accelerating the discovery, development and delivery of new and more effective treatment options for lung cancer patients.
Annual Revenue
$1,914,034
Known Funders
5
Grants Received
10
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $1,914,034 | $1,585,224 | $2,244,730 |
| 2023 | $1,553,569 | $1,112,960 | $1,490,643 |
| 2022 | $1,061,978 | $987,672 | $1,003,534 |
| 2021 | $1,553,644 | $1,086,366 | $1,036,268 |
| 2020 | $919,609 | $943,930 | $578,817 |
| 2019 | $987,238 | $977,138 | $472,232 |
| 2018 | $1,516,110 | $1,192,998 | $465,281 |
| 2017 | $938,310 | $938,854 | $255,575 |
Top Funders
Washington, DC
Washington, DC
Washington, DC
SAN MATEO, CA
SAN MATEO, CA
AUBURN, CA
SAN MATEO, CA
Wilmington, DE
AUBURN, CA
Key Personnel
From 2024 IRS 990 filing
Tom Krohn RPh MBA
Director
Richard Erwin
Sr. Dir. Clinical Operations
Tony Addario Chair
CEO
Ken Krantz
CEO
Bonnie Addario
Director
Bruce Gellman
Director
Gary Ingenito
Director
Steve Cavan Treasurer
Director
Frequently Asked Questions
Other Nonprofits in California
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.